Why Naturopaths need Evidenced-Based Rocketstars-Goldenberg

by | Jan 1, 2017

By Joshua Z. Goldenberg, ND

Warning, this article is going to be about evidence-based medicine (EBM). Check in with yourself. What are you feeling?

Joking aside, while EBM has become established over the past 20 years in conventional and integrative medicine environments, it is often still met with skepticism (Trinder 2000). Let’s explore that.

In the aptly titled BMJ paper “EBM what it is and what it isn’t,” David Sackett, arguably the father of EBM, defined it as the “conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients’’ further delineated as a confluence of physician experience, patient values, and best evidence (Sackett 1996).

The first two elements don’t ruffle too many feathers. Physician experience comes from just that, experience. Being respectful of and working with patient values is something I believe naturopaths specifically excel at, so no problem there. Rather it is the third “best evidence” element that I often see my students (ND or MD) struggle with. The reason for this struggle, I believe, comes down to two issues regarding medical research: there is too much of it and most of it isn’t very good.

In this essay I would like to discuss these two issues, suggest what we as clinicians can do about them, and argue why this is particularly important for naturopathic physicians.

Let us begin with the glut of medical research. There is a tome of research articles out there, and they are increasing at an exponential rate. Currently, Pubmed alone has more than 26 million citations. Gone are the days when you could get your JAMA in the mail each week, flip through it on the weekend, and feel up-to-date with current medical thinking.

And what about the quality of the deluge? Unfortunately, we can take little solace here either. Most research is of low methodological quality and likely reaches false conclusions and even the papers that look good initially should be suspect (Ioannidis 2005). Why? While there are many reasons, one is certainly because the classic EBM hierarchy, often depicted as a pyramid with systematic reviews and randomized controlled trials (RCTs) on top, has been “hijacked,” to quote John Ioannidis, a leading EBM proponent. He argues that vested interests have taken advantage of this hierarchy and often produce papers that appear to meet criteria for ‘top of the pyramid’ evidence but actually have a significant risk of bias which often requires some digging to uncover (Ioannidis 2016). Examples would include publication bias, weak comparator choice, selective outcome reporting, and spin in the abstract and discussion sections.

Advertisement

For these reasons, the overworked and time-poor physician has had to shift in practice to pre-appraised evidence sources such as UpToDate, Dynamed, practice guidelines, and others (Chapa 2013). While there are some issues with relying on pre-appraised evidence and some have argued this may actually undermine the anti-authoritarian nature of EBM to begin with (Goldenberg 2009), it is likely net positive and the time-saving nature of it is essential to any time-crunched physician.

Now comes the point where I tell you why we as naturopaths, in particular, need to be rockstars. While naturopathic researchers are toiling away every day establishing an evidence base for the profession, to date, naturopathic medicine has a relative dearth of high-quality clinical evidence. This thin evidence base makes evidence-based guidelines difficult to construct.

So, what is an evidence-based naturopath to do? Well, pragmatically this means that we tend to go directly to whatever primary research sources there are. Unfortunately, these often tend to be methodologically weaker and are of course rarely pre-appraised by a methodologist.

For this reason, I think we need to be our own methodologists. I know we went to naturopathic medical school to be clinicians, but I believe that modern medicine needs clinicians to also be partial scientists. We need to be able to identify relevant evidence, ruthlessly assess it, and apply it to our patients. But how do we do a good job at ferreting out bias and presenting only the most trustworthy material to our patients?

I have taught critical evaluation of the medical literature to NDs, MDs, DOs, chiropractors, medical students, and others. I have taught it online and in person. I have lectured in front of large classes and guided small journal clubs. I have taught day-long boot-camps and multiple-quarter-long training programs. So believe me when I say there are MANY tips and techniques you can learn to master evidence evaluation. However, you don’t need to be a master to start, but you do need to start somewhere.

Like our medical practices themselves, critical evaluation of the medical literature takes practice. While we left naturopathic medical school competent, we certainly didn’t leave as experts. That’s what a life of practice is all about: honing, refining, and becoming the best physician you can be. It is the same with research evaluation. Take a page out of Dr. Bastyr’s book and critically read an article every night, or at least once a week. Excellence will come with time and practice.

So with a bit of grace for yourself and the learning process, I would suggest that you start with three questions whenever you read a research paper.

Question number one. Can you trust it? This speaks to the risk of bias of the study. Some of these elements you likely already know such as checking for blinding, but there are many more domains and in depth tools you could use. I would recommend learning the Cochrane Risk of Bias Tool (Higgins 2011) if you wanted to do a deep dive, but the first thing I would look for is conflict of interest. Who are the authors of the paper? Who was the sponsor? Try to understand their motivations. Be skeptical. A quick scan of the authors and their affiliated institutions can be a tip off. Is one of the authors an employee of the company whose natural product is being investigated?

Question number two. How big is it? We often get so caught up in p values. While certainly important, p values only tell you about statistical significance. They tell you nothing about clinical significance. We need to be better at understanding the effect sizes of interventions. This could be described in risk ratios, odds ratios, numbers needed to treat, standardized mean differences, and more. While often confusing, try to get a sense of what the actual effect size is. Ask yourself, is this an important difference? Would this matter to my patient? For example, consider a study that found a statistically significant effect of supplement X on blood sugar but the mean treatment group had a fasting glucose of 188 post-treatment versus the control group’s 189. Would that statistically significant difference be significant to your patient?

Finally, question three. Does it apply to my patient? If the study passes the ‘trustiness test,’ and clinical relevance check, we need to then ask if it is applicable to our patient. For this I often advise my students to look at the baseline data table for the study participants. Are all the participants normotensive, normal weight, and of Asian descent while your patient is hypertensive, overweight and Caucasian? Is the analysis based on per protocol compliance but your patient at best does half the things you recommend? While a research study will rarely match up perfectly with your patient, at least see if you are in the same ball park.

In summary, busy clinicians who strive to practice in an evidence-based manner face the conundrum of a plethora of poor quality evidence from which to extract best evidence. To deal with this, clinicians have moved away from individual article review and towards point of care pre-appraised evidence. Unfortunately naturopaths (and any other medical provider in a field with limited clinical evidence) are forced to source directly from primary literature. This literature is often riddled with bias, much of it subtle and un-appraised. We must never accept the results of a paper at face value but rather be our own methodologists, our own ferreters of bias, our own critical evaluators of the medical literature rockstars.

Dr. Goldberg will be teaching a boot-camp on Evidence-Based Medicine for CEUs at the Bastyr University on February 25, 2017.

Bibliography

Chapa D, Hartung M, Mayberry L, Pintz C. Using preappraised evidence sources to guide practice decisions. Journal Of The American Association Of Nurse Practitioners. 2013; 25(5): p. 234-43.

Goldenberg MJ, Borgerson K, Bluhm R. The Nature of Evidence in Evidence-Based Medicine: Guest editors’ introduction. Perspectives in Biology and Medicine. 2009; 52(2). p 164-7.

Higgins JPT, Green S. (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.

Ioannidis JPA. Why Most Published Research Findings Are False. PLoS Medicine. 2005; 2(8). e124.

Ioannidis JPA. Evidence-based medicine has been hijacked: a report to David Sackett. Journal of Clinical Epidemiology. 2016; 73. p 82-6.

Sackett D, Rosenberg W, Gray J, Haynes R, Richardson W. Evidence based medicine: what it is and what it isn’t. BMJ. 1996; 312(7023). p. 71-2.

Trinder L, Reynolds S. Evidence-Based Practice: A Critical Appraisal. Oxford: Blackwell Science; 2000. p 249.

ALSO, this page has Goldenberg’s picture and bio (at the bottom): https://bastyr.edu/civicrm/event/info?id=2181&reset=1

Author

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

When Screens Replace Connection: Impact on Children’s Brains

By Erik Peper, PhD, BCB, Stoyan Vezenkov, PhD, Violeta Manolovab, Lauren Mason, PhD and Richard Harvey, PhD – The empirical record on educational technology in early and primary education has not delivered on its promises—math and reading scores have declined while screen use in classrooms has risen, as the US NAEP data and Sweden’s recent reversal of its “digital-first” education policy make plain.

Read More

The Pharmacy of the Sacred Forest: Medicinal Plants and Ancestral Wisdom of the Jola Healers (Gambia)

By Dr. Josep Lluís Berdonces – “Out of sight, out of mind,” goes a traditional proverb that Malang often repeats. The destruction of sacred forests, the loss of local languages, the disappearance of wise elders without passing on their knowledge: all of this represents a cultural and therapeutic catastrophe of incalculable dimensions.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This